Mustang Bio, Inc. (NASDAQ: MBIO) Rallies 15% After City of Hope Receives $9.28 Million Grant to Fund Phase 1 Trials For Treatment of HER2-Positive Breast Cancer with Brain Metastases
Mustang Bio, Inc. (NASDAQ: MBIO) operates as a clinical-stage biopharmaceutical company, which is focused on developing cell- and gene-based treatments ...
